Mexidol Tablets

The mexidol tablets are neuroprotective and antioxidant drug mainly composed of ethyl methyl hydroxy pyridine succinate. It works through multiple mechanisms such as effectively eliminating free radicals, stabilizing cell membranes, and improving brain tissue metabolism. It is widely used in clinical practice for the treatment of acute and chronic cerebrovascular diseases, post-traumatic sequelae of mild brain injury, anxiety disorders, and autonomic nerve dysfunction. This drug can significantly enhance the tolerance of brain tissue to ischemia and hypoxia, improve cognitive function, and alleviate neurological deficits. The standard dosage is oral administration. The specific dosage and treatment course should be strictly followed according to the doctor's advice and adjusted individually based on the patient's condition. The common dosage form is 125 milligram tablets. During medication, mild adverse reactions such as drowsiness and dry mouth may occur, which are usually tolerable. The contraindications include allergies to the drug components, severe liver and kidney dysfunction, and special populations such as pregnant and lactating women. Also, attention should be paid to its interaction with central nervous system inhibitory drugs.

Randomized Controlled Trials (RCTs)

◆ NIH Stroke Scale (NIHSS) scores: Reduced by 4.2 points vs. 2.1 points in placebo (p < 0.01).

◆ Modified Rankin Scale (mRS) scores: 65% achieved independence (mRS ≤ 2) vs. 45% in placebo (p = 0.03).

◆ Cognitive function: Montreal Cognitive Assessment (MoCA) scores increased by 3.5 points vs. 1.2 points in placebo (p = 0.008).

Subgroup analysis revealed that early initiation of emoxypine succinate (within 6 hours of stroke onset) yielded greater benefits, with a 30% reduction in infarct volume on MRI compared to placebo.

Sequential Therapy Study

A 2020 study of 50 patients with carotid-territory ischemic stroke compared sequential emoxypine succinate therapy (500 mg intravenously for 14 days, followed by emoxypine succinate Forte 250 mg orally three times daily for 60 days) to standard care. Emoxypine succinate-treated patients demonstrated:

◆ Faster neurological recovery: NIHSS scores improved by 60% at day 14 vs. 30% in controls (p = 0.002).

◆ Enhanced functional independence: 80% achieved Barthel Index scores ≥ 90 at 90 days vs. 50% in controls (p = 0.01).

◆ Reduced oxidative stress: Plasma malondialdehyde (MDA) levels decreased by 45% vs. 15% in controls (p < 0.001).

Real-World Data

A retrospective analysis of 200 ischemic stroke patients treated with emoxypine succinate in Russian stroke units reported that:

◆ Early administration (within 12 hours) reduced mortality by 20% compared to delayed initiation.

◆ Combination with thrombolysis improved 90-day functional outcomes (mRS ≤ 2 in 70% vs. 50% with thrombolysis alone; p = 0.04).

◆ Safety profile: Adverse events (e.g., nausea, headache) occurred in 8% of patients, with no serious drug-related complications.

The antioxidant effects of emoxypine succinate tablets (ethyl methyl hydroxypyridine succinate tablets) are one of their core pharmacological mechanisms, primarily achieved by inhibiting free radical production, enhancing antioxidant enzyme activity, neutralizing lipid peroxides, and regulating oxidative stress-related signaling pathways. The specific mechanisms are as follows:

Emoxypine succinate tablets (ethyl methyl hydroxypyridine succinate tablets) have an adjunctive therapeutic effect in chronic cerebrovascular diseases, primarily through mechanisms such as antioxidant activity, membrane stabilization, and improvement of cerebral circulation, thereby alleviating neuronal damage caused by chronic cerebral ischemia. However, they should be used in combination with other medications and in accordance with individualized treatment principles. The following sections provide an overview of the mechanism of action, clinical application, and precautions:

► Mechanism of Action: Multi-target protection of chronic ischemic brain tissue

Antioxidant and membrane-stabilizing effects: emoxypine succinate scavenges free radicals and enhances the activity of endogenous antioxidant enzymes, thereby reducing lipid peroxidation and protein oxidation. This protects neurons and vascular endothelial cells from oxidative damage caused by chronic ischemia. Additionally, its membrane-stabilizing effects maintain cellular membrane fluidity, prevent calcium overload and excitatory amino acid toxicity, and inhibit neuronal apoptosis.

Improved cerebral circulation: emoxypine succinate dilates cerebral blood vessels, inhibits platelet aggregation, and promotes the establishment of collateral circulation, thereby increasing blood supply to chronically ischemic regions and alleviating neuronal metabolic disorders caused by prolonged hypoxia.

Neuroprotection and repair: By regulating neurotransmitter balance (e.g., dopamine, glutamate) and promoting the expression of neurotrophic factors, emoxypine succinate aids in the repair of neural function impaired by chronic ischemia.

► Clinical application: As part of comprehensive treatment

Combination therapy: emoxypine succinate is typically used in combination with antiplatelet agents (such as aspirin) and statins (such as atorvastatin) to enhance therapeutic efficacy. For example, in patients with chronic cerebral ischemia, emoxypine succinate can improve cerebral metabolism and microcirculation, alleviating symptoms such as dizziness, headache, and difficulty concentrating.

Long-Term Treatment: For patients with chronic cerebrovascular diseases, emoxypine succinate can be used as a long-term maintenance therapy to slow disease progression. Its oral formulations (e.g., emoxypine succinate Forte 250mg tid) are convenient for long-term use and have good safety profiles with a low incidence of adverse reactions.

Individualized adjustment: The dosage and duration of emoxypine succinate should be adjusted individually based on the patient's condition and tolerance. For example, for elderly patients or those with impaired renal function, the dosage should be appropriately reduced to avoid adverse reactions.

The core mechanism of antioxidant effects

► Inhibiting free radical generation

Emoxypine succinate tablets reduce the production of free radicals (such as superoxide anions and hydroxyl radicals) by blocking the lipid peroxidation (LPO) chain reaction. Free radicals are key factors in causing cell membrane damage, protein oxidation, and DNA breaks. Their excessive accumulation is closely related to aging, neurodegenerative diseases, and systemic inflammation.

Enhancing antioxidant enzyme activity

Emoxypine succinate tablets significantly enhance the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). These enzymes are central to the cellular antioxidant defense system, neutralizing free radicals and repairing oxidative damage. For example, preclinical studies show that emoxypine succinate tablets can increase SOD activity by 30%-50%, thereby enhancing cellular resistance to oxidative stress.

► Neutralization of lipid peroxides

Emoxypine succinate tablets directly neutralize toxic byproducts such as hydrogen peroxide (H₂O₂) and malondialdehyde (MDA) produced during lipid peroxidation by providing hydrogen atoms or electrons, thereby preventing further damage to cell membranes and organelles. This action helps maintain the integrity and fluidity of cell membranes.

► Regulation of oxidative stress signaling pathways

Emoxypine succinate tablets may activate the Nrf2/ARE pathway (nuclear factor E2-related factor 2/antioxidant response element pathway) to promote the expression of antioxidant genes (such as SOD, GPx, and heme oxygenase-1), thereby enhancing the cell's long-term antioxidant capacity. Additionally, it can inhibit the NF-κB pathway (nuclear factor κB pathway) to reduce the release of inflammatory factors, further alleviating oxidative stress-induced tissue damage.

► Neuroprotection

In acute ischemic stroke or chronic cerebral ischemia, oxidative stress is one of the primary causes of neuronal death. Emoxypine succinate tablets, through their antioxidant effects, can reduce infarct volume, improve neurological recovery, and lower the risk of cognitive impairment. For example, in the MIR trial, early use of emoxypine succinate tablets reduced infarct volume by 30% while improving patients' activities of daily living scores (Barthel Index).

► Anti-Aging and Cognitive Improvement

Oxidative stress is a key driver of aging, leading to memory decline and cognitive impairment. Emoxypine succinate tablets may slow the aging process in the brain by neutralizing free radicals, thereby improving attention, memory, and executive function. Animal studies show that long-term use of emoxypine succinate tablets significantly reduces oxidative damage in the hippocampus of aged rats and enhances their spatial learning ability.

► Organ Protection

The antioxidant effects of emoxypine succinate tablets are not limited to the nervous system but also extend to organs such as the heart, liver, and kidneys. For example, in acute myocardial infarction, emoxypine succinate tablets can reduce myocardial cell apoptosis and minimize infarct size; in alcoholic liver injury, it can lower liver enzyme levels and alleviate hepatic steatosis.

► Anti-inflammatory and Immunomodulatory Effects

Oxidative stress is closely associated with inflammatory responses. By inhibiting oxidative stress, emoxypine succinate tablets can indirectly reduce the release of inflammatory factors (such as IL-6 and TNF-α), thereby exerting anti-inflammatory effects. This property makes them potentially valuable in autoimmune diseases and chronic inflammatory conditions.

The side effects of emoxypine succinate tablets (ethyl methyl hydroxypyridine succinate tablets) are generally mild and occur at a low rate, primarily including gastrointestinal discomfort and skin-related reactions, as detailed below:

◆ Gastrointestinal discomfort:

Common reactions: These include dry mouth, nausea, stomach pain, burning sensation, discomfort, heartburn, bloating, and diarrhea. These reactions are generally mild and may improve or resolve with continued use or dose adjustment.

Severity: While these gastrointestinal reactions may cause discomfort, they generally do not pose a serious health risk. However, emoxypine succinate tablets should be used with caution in patients with weakened gastrointestinal function, and gastrointestinal reactions should be closely monitored during treatment.

◆ Skin reactions:

Possible manifestations: emoxypine succinate tablets may cause skin reactions such as rash or itching. These reactions are generally rare but should be taken seriously if they occur.

Management recommendations: Patients experiencing skin reactions should discontinue the medication immediately and consult a physician to determine whether to continue using emoxypine succinate tablets or switch to an alternative medication.

◆ Other potential reactions:

Individual variability: Although the side effects of emoxypine succinate tablets are generally mild, different patients may exhibit varying reactions due to individual differences. For example, some patients may be allergic to certain components in emoxypine succinate tablets, leading to allergic reactions.

Monitoring and adjustment: During treatment, patients should closely monitor their reactions. If any discomfort or abnormal symptoms occur, they should promptly inform their doctor. The doctor will adjust the dosage or switch medications based on the patient's specific condition to ensure safe and effective use of the medication.

1. What diseases is Mexidol mainly used to treat?
It is mainly used for treating cerebrovascular diseases (such as post-stroke sequelae), anxiety neuroses, cognitive dysfunction and autonomic nerve disorders, exerting the functions of neuroprotection and improving brain metabolism.
2. How long does it usually take to complete the course of medication?
The duration of treatment varies from person to person and depends on the specific condition. Generally, one treatment course lasts for several weeks to several months. It is essential to strictly follow the doctor's prescription and must not take the medication for an extended period or stop taking it suddenly.
3. What are the common side effects?
The side effects are usually mild and may include drowsiness, dry mouth, nausea or mild gastrointestinal discomfort. If the symptoms persist or worsen, it is advisable to consult a doctor promptly.
4. What are the important precautions when taking this medication?
Those who are allergic to the drug ingredients, pregnant women and lactating mothers, as well as those with severe liver or kidney dysfunction should avoid using it. During the medication period, alcohol consumption should be avoided. It is also necessary to be cautious when driving or operating precision instruments as it may cause drowsiness.

Hot Tags: mexidol tablets, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale